FDA approves whooping cough vaccine for pregnant mothers
The Food and Drug Administration authorised a new vaccination to prevent whooping cough in newborn newborns on Friday
GlaxoSmithKline produces Boostrix, which is intended for usage during the third trimester of pregnancy
It was the first vaccination approved by the agency that protects newborns from disease by giving their moms a shot during pregnancy
Marks stated in a statement that "pertussis disease is a highly contagious respiratory ailment affecting all age groups."
However, babies are most susceptible to contracting pertussis and suffering terrible side effects from it
According to the FDA, the single-shot vaccine was 78% effective in preventing whooping cough in newborn infants
FOR MORE STORIES